HPV vaccination prevents genital warts in males

Feb 04, 2011 by Lin Edwards report

(PhysOrg.com) -- A new international study shows the human papillomavirus (HPV) vaccine protects against genital warts and other lesions associated with HPV in males. HPV is the most common sexually transmitted disease and affects men and women. It has been linked to genital warts and cancers of the cervix and, more rarely, cancers of the vagina, anus, penis and mouth.

The protects against four types of HPV infection: HPV-6, HPV-11, HPV-16, and HPV-18, and potentially also protects against or other lesions associated with these infections. Two HPV vaccines — Cervarix and Gardasil — are now recommended for girls aged nine and over to prevent cervical cancer.

Gardasil is also FDA-approved as a prevention of genital warts associated with HPV-6 and HPV-11, and in October 2010 was recommended for optional use in boys and young men from 9 to 26. The current study was carried out because until now the focus has been on using the to prevent and little research has been done on the effects of the vaccine in men.

The study included over 4,000 sexually active males aged 16 to 26 and originating from 18 countries and was a randomized double-blind and placebo-controlled clinical trial. There were two groups of subjects: one group was free of HPV at the start, and were given the vaccine; the other group were not all free of HPV at the start and were given either the vaccine or a placebo regardless of their HPV status.

The subjects were followed for the next two to three years and in the first group the efficacy against HPV-related lesions was over 90 percent. In the second group, of those given the vaccine only about 0.5 percent developed genital warts, while around 2.8 percent of those who received the placebo developed them. There was also a reduction in the incidence of HPV infections lasting for six months or more in those who were given the vaccine, but the difference was less dramatic.

Leaders of the study were Dr Anna Giuliano from the H. Lee Moffitt Cancer Center and Research Institute in Tampa, Florida, and Dr Joel Palefsky of the University of California, San Francisco. Dr Giuliano said Gardasil vaccine can prevent external infections, which means if boys are vaccinated early enough most cases of genital warts can be prevented. This raises the question of whether or not all boys and young men should be encouraged to be vaccinated. Dr Palefsky said the “burden of vaccination should not fall solely on girls and women” because men are affected by HPV as well as women. Men who have homosexual sex would not benefit from vaccination of girls and women.

Dr Palefsky said the vaccine appears to be safe, but the disadvantage is that a universal vaccination program of males would be costly, and most of the serious diseases caused by HPV, such as cervical , affect only women.

The results of the study, published in the New England Journal of Medicine did not look at the effects of the vaccine on cancers. Merck, the manufacturer of Gardasil, designed and funded the research and analyzed the data, with the help of Drs Giuliano, Palefsky and colleagues. Additional funding was provided by the National Institutes of Health. Several members of the research team, including Dr Giuliano, also received speaking fees, travel cost reimbursements, or fees for board membership from Merck. Other members of the research team are employees of Merck and own Merck stock or options.

Explore further: More than a quarter of emergency contraceptives in Peru falsified or substandard

More information: Efficacy of Quadrivalent HPV Vaccine against HPV Infection and Disease in Males: N Engl J Med 2011; 364:401-411. www.nejm.org/doi/full/10.1056/NEJMoa0909537

Related Stories

Some men want girls' vaccine, too

Feb 23, 2007

Some British gay men want to be vaccinated with the drug approved to protect girls from cervical cancer, saying it could help them, too.

FDA considers expanded use of HPV vaccine

Mar 20, 2008

Pharmaceutical manufacturer Merck & Co. Inc. said the U.S. Food and Drug Administration will consider expanding the use of its cervical cancer vaccine.

New HPV vaccine under study

Nov 19, 2007

A new vaccine against nine of the most harmful strains of human papillomavirus is under study at the Medical College of Georgia.

HPV vaccines may reduce a wide range of genital diseases

Feb 05, 2010

High-coverage human papillomavirus (HPV) vaccinations among adolescents and young women may result in a rapid reduction of genital warts, cervical cell abnormalities, and diagnostic and therapeutic procedures, researchers ...

Recommended for you

Study recalculates costs of combination vaccines

Apr 17, 2014

One of the most popular vaccine brands for children may not be the most cost-effective choice. And doctors may be overlooking some cost factors when choosing vaccines, driving the market toward what is actually a more expensive ...

Drug watchdog urges vigilance in cancer drug theft

Apr 17, 2014

Europe's medicine watchdog urged doctors Thursday to be vigilant in administering the cancer drug Herceptin, vials of which had been stolen in Italy and tampered with before being sold back into the supply chain.

User comments : 4

Adjust slider to filter visible comments by rank

Display comments: newest first

Moebius
5 / 5 (4) Feb 04, 2011
I can't believe the stupidity of this. They won't give it to older men. Who are more likely to have had more sex partners and more likely to need it. And they never mention in any article I've read its effect on people who are already infected. Guess no one would want to know that.
Chef
5 / 5 (1) Feb 04, 2011
So the analysis was not done independently and they were paid extra for speaking, travel fees, and/or reimbursed for costs, as well as run by share holders. Yeah, I trust that review.
Hesca419
not rated yet Feb 04, 2011
"In the second group, of those given the vaccine only about 0.5 percent developed genital warts, while around 2.8 percent of those who received the placebo developed them."

Yeah, it's not enough, but that's the info they give on the people who were already infected. No information on their ability to carry the infection, which I really thought would have been key.

I suspect they'll give it to whomever will pay for it. I just wouldn't expect insurance to help. Like birth control, it will likely remain a "woman's problem" from their point-of-view.

Still, I wonder if I can talk a doc into hooking me up with some of this... if only it wasn't $400!
pozlove
not rated yet Feb 06, 2011
It was reported that "The virus is spread through all types of close sexual contact but using condoms and vaccination against HPV will reduce the risk."

Check more HPV support site on HPVmatch.net!!!

More news stories

Less-schooled whites lose longevity, study finds

Barbara Gentry slowly shifts her heavy frame out of a chair and uses a walker to move the dozen feet to a chair not far from the pool table at the Buford Senior Center. Her hair is white and a cough sometimes interrupts her ...

How to keep your fitness goals on track

(HealthDay)—The New Year's resolutions many made to get fit have stalled by now. And one expert thinks that's because many people set their goals too high.

Low tolerance for pain? The reason may be in your genes

Researchers may have identified key genes linked to why some people have a higher tolerance for pain than others, according to a study released today that will be presented at the American Academy of Neurology's 66th Annual ...

Growing app industry has developers racing to keep up

Smartphone application developers say they are challenged by the glut of apps as well as the need to update their software to keep up with evolving phone technology, making creative pricing strategies essential to finding ...

Making graphene in your kitchen

Graphene has been touted as a wonder material—the world's thinnest substance, but super-strong. Now scientists say it is so easy to make you could produce some in your kitchen.